Table 1 Patient characteristics
Group 0 (n = 26) | Group − 10 (n = 27) | Group − 30 (n = 26) | |
|---|---|---|---|
Age (years) | 47.2 (11.4) | 53.7 (14.0) | 48.3 (12.5) |
Sex (male/female) | 7/19 | 9/18 | 10/16 |
Weight (kg) | 58.7 (9.7) | 60.5 (11.8) | 62.4 (12.5) |
Height (cm) | 162 (6) | 163 (8) | 164 (8) |
BMI (kg/m2) | 22.3 (2.9) | 22.8 (3.5) | 23.0 (3.3) |
VATS side (left/right) | 12/14 | 15/12 | 15/11 |
Location of lung nodule | 8 (30.8%) | 8 (29.6%) | 10 (38.5%) |
ASA [n (%)] | |||
I | 11 (42.3%) | 8 (29.6%) | 12 (46.2%) |
II | 15 (57.7%) | 18 (66.7%) | 14 (53.8%) |
III | 0 (0.0%) | 1 (3.7%) | 0 (0.0%) |
Preemptive OLV (min) | 6.7 (1.9) | 7.3 (2.0) | 7.2 (2.7) |
Skin incision (min) | 1.6 (0.8) | 1.6 (0.7) | 1.7 (0.6) |
Trocar placement (min) | 1.2 (0.4) | 1.4 (1.0) | 1.1 (0.6) |
Surgery duration (min) | 44.8 (10.9) | 50.0 (30.7) | 42.7 (17.5) |
Tumor size (mm) | 8.9 (3.2) | 8.3 (2.8) | 7.7 (2.5) |
Histology [n (%)] | |||
Inflammation/ Benign tumors | 4 (15.4%) | 3 (11.1%) | 1 (3.8%) |
Adenocarcinoma | 22 (84.6%) | 23 (85.2%) | 25 (96.2%) |
SCLC | 0 (0.0%) | 1 (3.7%) | 0 (0.0%) |
Tumor stage [n (%)] | 22 (84.6%) | 24 (88.9%) | 25 (96.2%) |
Tis | 2 (7.7%) | 3 (11.1%) | 3 (11.5%) |
T1 | 20 (76.9%) | 21 (77.8%) | 22 (84.6%) |
Tumor size (mm) | 8.9 (3.2) | 8.3 (2.8) | 7.7 (2.5) |